These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32240484)

  • 21. [Diagnosis and treatment of disease 2019 novel coronavirus infection suitable for Military support Hubei medical team].
    Military Medical Expert Group on the Front-line
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):285-287. PubMed ID: 32294812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Curing COVID-19.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2020 Oct; 20(10):1101. PubMed ID: 32919520
    [No Abstract]   [Full Text] [Related]  

  • 23. [Characteristics of SARS-CoV-2 and potential pharmacological treatment].
    Pawlik L; Śpiołek E; Fichna J; Tarasiuk A
    Postepy Biochem; 2020 May; 66(2):83-90. PubMed ID: 32700510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey on the situation of telepharmacy as applied to the outpatient care in hospital pharmacy departments in Spain during the COVID-19 pandemic.
    Tortajada-Goitia B; Morillo-Verdugo R; Margusino-Framiñán L; Marcos JA; Fernández-Llamazares CM
    Farm Hosp; 2020 Jul; 44(4):135-140. PubMed ID: 32646343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients.
    Pan HD; Yao XJ; Wang WY; Lau HY; Liu L
    Pharmacol Res; 2020 Sep; 159():105043. PubMed ID: 32569819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics and drug therapies in patients with the common-type coronavirus disease 2019 in Hunan, China.
    Huang Q; Deng X; Li Y; Sun X; Chen Q; Xie M; Liu S; Qu H; Liu S; Wang L; He G; Gong Z
    Int J Clin Pharm; 2020 Jun; 42(3):837-845. PubMed ID: 32410206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy.
    Margusino-Framiñán L; Illarro-Uranga A; Lorenzo-Lorenzo K; Monte-Boquet E; Márquez-Saavedra E; Fernández-Bargiela N; Gómez-Gómez D; Lago-Rivero N; Poveda-Andrés JL; Díaz-Acedo R; Hurtado-Bouza JL; Sánchez-Gundín J; Casanova-Martínez C; Morillo-Verdugo R
    Farm Hosp; 2020 Jun; 44(7):61-65. PubMed ID: 32533674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
    Sarzi-Puttini P; Giorgi V; Sirotti S; Marotto D; Ardizzone S; Rizzardini G; Antinori S; Galli M
    Clin Exp Rheumatol; 2020; 38(2):337-342. PubMed ID: 32202240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical care in hospitalized patients. (Management of the COVID-19 pandemic crisis. A new challenge for pharmacy services).
    Sevilla-Sánchez D; Tuset-Creus M
    Farm Hosp; 2020 Jun; 44(7):28-31. PubMed ID: 32533666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specialized pharmaceutical care in social health centers in the times of COVID-19.
    Peris-Martí JF; Bravo-José P; Sáez-Lleó C; Fernández-Villalba E
    Farm Hosp; 2020 Jun; 44(7):43-48. PubMed ID: 32533670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacy Department management and organization.
    Herranz-Alonso A; Rodríguez-González CG; Sarobe-González C; Álvarez-Díaz A; Sanjurjo-Sáez M
    Farm Hosp; 2020 Jun; 44(7):5-10. PubMed ID: 32533661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to face the novel coronavirus infection during the 2019-2020 epidemic: the experience of Sichuan Provincial People's Hospital.
    Pan L; Wang L; Huang X
    Intensive Care Med; 2020 Apr; 46(4):573-575. PubMed ID: 32072300
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
    Shah M; Sachdeva M; Dodiuk-Gad RP
    Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacologic Therapy for COVID-19 Infection.
    Nusbaum N
    J Community Health; 2020 Jun; 45(3):435-436. PubMed ID: 32314081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital pharmacist challenges in evaluation of scientific evidence and its incorporation to pharmacotherapeutic protocols through therapeutic committees in COVID-19 times.
    Fernández-Llamazares CM; López-Briz E
    Farm Hosp; 2020 Jun; 44(7):24-27. PubMed ID: 32533665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. China empowers Internet hospital to fight against COVID-19.
    Sun S; Yu K; Xie Z; Pan X
    J Infect; 2020 Jul; 81(1):e67-e68. PubMed ID: 32251688
    [No Abstract]   [Full Text] [Related]  

  • 37. Hospital Pharmacist experience in the Intensive Care Unit: Plan COVID.
    García-Gil M; Velayos-Amo C
    Farm Hosp; 2020 Jun; 44(7):32-35. PubMed ID: 32533667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health systems preparedness during COVID-19 pandemic: China and India.
    Baru RV
    Indian J Public Health; 2020 Jun; 64(Supplement):S96-S98. PubMed ID: 32496234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.
    Stringer KA; Puskarich MA; Kenes MT; Dickson RP
    Pharmacotherapy; 2020 May; 40(5):382-386. PubMed ID: 32267979
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical consideration and management of coronavirus disease 2019].
    Ma K; Chen T; Han MF; Guo W; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):222-228. PubMed ID: 32306656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.